Forecast: Import of Ambergris, Civet, Musk for Pharmaceutical Use to China

The forecasted import value of ambergris, civet, and musk for pharmaceutical use into China is set to see a steady increase from 2024 to 2028. In 2024, the forecasted value starts at 4.012 million USD, growing to 4.3502 million USD by 2028. The data indicates a yearly growth rate that highlights China’s increasing demand for these substances in the pharmaceutical industry.

• Year-on-year growth illustrates a gradual rise in import value, suggesting a stable yet modest upward trend.
• The Compound Annual Growth Rate (CAGR) over the five-year forecast period reflects this consistent growth trajectory.

Given current market conditions and regulatory changes, potential future trends to watch include environmental and ethical sourcing pressures, technological advancements in synthetic alternatives, and shifts in global trade policies affecting supply chains. These factors may significantly influence the trajectory of imports beyond the forecast period.